Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
4.02
0.43
10.70%
Share Warrants & Outstandings
Total Reserve
-6.44
11.66
-18.10
-155.23%
Shareholder's Funds
-1.99
15.68
-17.67
-112.69%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.09
1.38
6.71
486.23%
Secured Loans
5.10
0.40
4.70
1,175.00%
Unsecured Loans
2.99
0.98
2.01
205.10%
Deferred Tax Assets / Liabilities
-0.19
0.01
-0.20
-2,000.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.51
1.39
6.12
440.29%
Current Liabilities
Trade Payables
10.22
13.65
-3.43
-25.13%
Other Current Liabilities
2.24
0.77
1.47
190.91%
Short Term Borrowings
0.00
8.08
-8.08
-100.00%
Short Term Provisions
0.59
0.00
0.59
0.00%
Total Current Liabilities
13.04
22.49
-9.45
-42.02%
Total Liabilities
18.56
39.55
-20.99
-53.07%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.69
2.85
14.84
520.70%
Less: Accumulated Depreciation
9.72
0.34
9.38
2,758.82%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.97
2.51
5.46
217.53%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
8.61
-8.61
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
0.34
0.06
17.65%
Long Term Loans & Advances
0.18
0.88
-0.70
-79.55%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
8.56
12.34
-3.78
-30.63%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.31
0.10
3.21
3,210.00%
Sundry Debtors
1.28
26.58
-25.30
-95.18%
Cash and Bank
0.09
0.33
-0.24
-72.73%
Other Current Assets
0.00
0.16
-0.16
-100.00%
Short Term Loans and Advances
5.32
0.05
5.27
10,540.00%
Total Current Assets
10.00
27.22
-17.22
-63.26%
Net Current Assets (Including Current Investments)
-3.03
4.73
-7.76
-164.06%
Total Current Assets Excluding Current Investments
10.00
27.22
-17.22
-63.26%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18.56
39.55
-20.99
-53.07%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.32
9.46
-2.14
-22.62%
Book Value per share (adjusted)
-4.47
38.99
-43.46
-111.46%
Annual - Borrowings
Borrowings 7.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Annual - Investments
Investments 0.40 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
